RPA Institute of Academic Surgery, University of Sydney, Australia; Department of Transplant Surgery, Royal Prince Alfred Hospital, University of Sydney, Australia.
University of Sydney Medical School, Australia.
Transplant Rev (Orlando). 2022 Jan;36(1):100652. doi: 10.1016/j.trre.2021.100652. Epub 2021 Sep 16.
Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) frequently undergo native nephrectomy before transplantation. The nephrectomy may be a staged procedure or undertaken simultaneously with transplantation. When performed simultaneously, the transplant procedure is more prolonged, involves a larger operative field and incision. There is also a concern of a greater risk of graft loss with simultaneous nephrectomy and transplantation. Moreover, staged surgery may allow nephrectomy to be performed before immunosuppression introduction via a smaller incision or involving a minimally invasive approach. However, staged nephrectomy may require a period of dialysis not otherwise necessary if a transplant and nephrectomy were simultaneous. Moreover, only a single procedure is needed, implying the avoidance of a prior nephrectomy and its attendant morbidity in a patient with chronic renal insufficiency. To account for these issues, this study aims to compare the cumulative morbidity of two-staged procedures versus a single simultaneous approach in term of morbidity and graft outcomes.
This study aims to systematically review the literature to determine whether a staged or simultaneous approach to native nephrectomy in ADPKD is the optimal approach in terms of morbidity and graft outcomes.
A literature search of MEDLINE and EMBASE was conducted to identify published systematic reviews, randomized control trials, case-controlled studies and case studies. Data comparing outcomes of staged and simultaneous nephrectomy for patients undergoing kidney transplantation was extracted and analyzed. The main outcomes analyzed were length of hospitalization, blood loss, operative time, other early postoperative complications and risk of graft thrombosis. Meta-analysis was conducted where appropriate.
Seven retrospective cohort studies were included in the review. There was a total of 385 patients included in the analysis, of whom 273 patients underwent simultaneous native nephrectomy and kidney transplantation. Meta-analysis showed an increased cumulative operative time in staged procedures (RR 1.86;95% CI 0.43-3.29 p = 0.01) and increased risk of blood transfusions (RR 2.69; 95% CI 1.92-3.46 p < 0.00001). For the transplant procedure, there were no significant difference in the length of stay (RR 1.03; 95% CI -2.01-4.14 p = 0.52), major postoperative complications (RR 0.02; 95% CI -0.15-0.10 p = 0.74) and vascular thromboses (RR 1.42 95% CI 0.23-8.59 p = 0.7).
The results suggest that staged nephrectomy followed by kidney transplantation is associated with a longer cumulative operative time and increased cumulative risk of blood transfusions. There is no evidence to suggest that performing a simultaneous nephrectomy and kidney transplant procedure increases the perioperative mortality rate, major postoperative complication rates or risk of vascular thrombosis.
常染色体显性多囊肾病 (ADPKD) 患者在移植前经常接受肾切除术。该切除术可以分期进行,也可以与移植同时进行。同期进行时,移植手术时间更长,涉及更大的手术区域和切口。同时进行肾切除术和移植术也存在移植物丢失风险增加的问题。此外,分期手术可能允许通过更小的切口或微创方法在引入免疫抑制之前进行肾切除术。但是,如果同时进行移植和肾切除术,则需要进行一段时间的透析,否则透析是不必要的。此外,对于慢性肾功能不全的患者,只需进行一次手术,即可避免之前的肾切除术及其伴随的发病率。为了考虑到这些问题,本研究旨在比较分期手术与单次同期手术在发病率和移植物结局方面的累积发病率。
本研究旨在系统地回顾文献,以确定在 ADPKD 中,分期或同期进行肾切除术作为减少发病率和改善移植物结局的最佳方法。
对 MEDLINE 和 EMBASE 进行文献检索,以确定已发表的系统评价、随机对照试验、病例对照研究和病例研究。提取并分析比较分期和同期肾切除术治疗接受肾移植患者的结果。分析的主要结果是住院时间、失血量、手术时间、其他术后早期并发症和移植物血栓形成风险。在适当的情况下进行了荟萃分析。
本研究共纳入了 7 项回顾性队列研究。共有 385 名患者纳入分析,其中 273 名患者同时接受了肾切除术和肾移植。荟萃分析显示,分期手术的累积手术时间更长(RR 1.86;95%CI 0.43-3.29,p=0.01),输血风险增加(RR 2.69;95%CI 1.92-3.46,p<0.00001)。对于移植手术,住院时间(RR 1.03;95%CI -2.01-4.14,p=0.52)、主要术后并发症(RR 0.02;95%CI -0.15-0.10,p=0.74)和血管血栓形成(RR 1.42 95%CI 0.23-8.59,p=0.7)无显著差异。
结果表明,分期肾切除术加肾移植与更长的累积手术时间和更高的累积输血风险相关。没有证据表明同时进行肾切除术和肾移植会增加围手术期死亡率、主要术后并发症发生率或血管血栓形成风险。